AzTrials
AzTrials

Postoperative Pain, AcuteNCT06403462

Transversalis Fascia Plane Block for Iliac Bone Graft in Children

A study testing transversalis fascial plane block and transversus abdominis plane block in people with Postoperative Pain, Acute, run by Seoul National University Hospital at 1 site in South Korea.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine which method is more effective in postoperative pain control in children undergoing iliac bone grafting for alveoloplasty under general anesthesia: ultrasound-guided transverse abdominal blockade or transversalis fascia plane block Read more about this study

Who is it for?
Ages 7 to 18 yearsHealthy volunteers can take part
Conditions the study is for
Postoperative Pain, Acute
What is being tested?
transversalis fascial plane block and transversus abdominis plane block
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteSouth Korea
Study dates
7 May 2024to 31 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 18 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Children aged 7 years and older but under 18 undergoing iliac bone grafting for alveoloplasty

Who cannot join

  • Patients with diseases that affect pain sensitivity differently from the general population (e.g., congenital insensitivity to pain with anhidrosis, complex regional pain syndrome, etc.)
  • Cases where there is difficulty in expressing pain (due to cognitive or functional deficits, or limited ability to communicate)
  • Unstable vital signs (heart rate, blood pressure)
  • Common contraindications for Ropivacaine: 1) Patients with a history of hypersensitivity to this drug or other amide local anesthetics, 2) Patients in a state of major bleeding or shock, 3) Patients with inflammation at or around the site of administration, 4) Patients with sepsis, 5) Intravenous regional anesthesia (Bier block)
  • History of allergy to opioid medications
  • Severe renal impairment (Creatinine >3.0mg/dL)
Show all 9Show fewer
  • Severe liver function abnormalities (aspartate transaminase > 120 unit/L, alanine aminotransferase > 120 unit/L)
  • Peripheral nervous system disorders
  • Other cases deemed unsuitable by the researcher

Trial locations and contacts

1 site in 1 country.

South Korea1 site
  • Seoul National University Children's Hospital

    Seoul, 110-744

Other trials in South Korea

About this study

Official title: Comparison Between Ultrasound-guided Transversus Abdominis Plane and Transversalis Fascia Plane Block for Pediatric Patients Undergoing Alveoloplasty With Iliac Bone Graft: a Prospective Randomized Controlled Trial

The purpose of this study is to determine which method is more effective in postoperative pain control in children undergoing iliac bone grafting for alveoloplasty under general anesthesia: ultrasound-guided transverse abdominal blockade or transversalis fascia plane block

Being tested
transversalis fascial plane block, transversus abdominis plane block
Medical subject headings
Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • transversalis fascial plane blockProcedure or surgery

    ultrasound guidance transversalis fascial plane block after iliac bone graft

  • transversus abdominis plane blockProcedure or surgery

    ultrasound guidance posterior transversus abdominis plane block after iliac bone graft

Study groups in NCT06403462
Study groupRoleWhat they receive
transversus abdominis plane blockActive comparatorNot described
Receives: Procedure: transversus abdominis plane block
transversalis fascial plane blockExperimentalNot described
Receives: Procedure: transversalis fascial plane block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. total consumption of opioid (mcg/kg)

    total opioid consumption at 24 hours after the end of surgery

    Measured: from the end of surgery up to 24 hours later

Secondary outcomes (6)
  1. Postoperative Pain score

    Pain scores is assessed by Numerical Rating Scale, which requires the patient to rate their pain on a defined scale. For example, 0-10 where 0 is no pain and 10 is the worst pain imaginable

    Measured: at 30 minutes, 1 hour, 3 hours, 6 hours, 24 hours after the end of surgery

  2. Total consumption of non-opioid (mg/kg)

    Non-opioid analgesics usage per body weight within 24 hours after surgery

    Measured: within 24 hours after the end of surgery

  3. Cold sensation

    Evaluation of the distribution of lost cold sensation in the skin in the recovery room (Dermatomal distribution of the loss of cold sensation using an alcohol swab at post-anesthesia care unit, assessed by a blinded assessor in the Post Anesthesia Care Unit).

    Measured: at 30 minutes after the end of surgery

  4. The incidence of side effects of analgesic medications (percent)

    Analgesic-related side effects (nausea, vomiting, constipation, pruritis, dizziness, dry mouth, somnolence, etc.) within 24 hours after surgery.

    Measured: within 24 hours after the end of surgery

  5. Satisfaction score

    Patient satisfaction score (0-10 points, with 10 being very satisfied and 0 being very dissatisfied).

    Measured: at 24 hours after the end of surgery

  6. Sleep quality score

    Quality of sleep on the day of operation (satisfaction score, 0-10 points, with 10 being very satisfied and 0 being very dissatisfied).

    Measured: at 24 hours after the end of surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 May 2024
  2. Study start7 May 2024
  3. Primary completion30 Dec 2025
  4. Study completion31 Dec 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06403462
Sponsor's protocol ID
H-2311-167-1488
Status last verified
Apr 2026
First submitted
3 May 2024
Last updated
14 Apr 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing transversalis fascial plane block and transversus abdominis plane block in people with Postoperative Pain, Acute, run by Seoul National University Hospital at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

total consumption of opioid (mcg/kg) (time frame: from the end of surgery up to 24 hours later). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in